Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation at 42nd Annual JP Morgan Healthcare Conference10-01-2024
10-01-2024
Mankind Pharma Ltd - 543904 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 201806-01-2024
Drug pricing watchdog fixes retail rates for 19 formulations, including cancer pills
Cancer medication Trastuzumab manufactured by Hetero Biopharma Limited and Mankind Pharma Limited will have a ceiling price of Rs 15817.49 per vial.04-01-2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of participation in 42nd Annual JP Morgan Healthcare Conference02-01-2024
Mankind Pharma Ltd - 543904 - Closure of Trading Window
Closure of Trading Window under SEBI (PIT) Regulations, 2015 and the Company''s ''Code of Conduct for Prevention of Insider Trading''27-12-2023
Mankind Pharma Ltd - 543904 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Beige Ltd & Link Investment Trust20-12-2023
Mankind Pharma gains on raising stake in British therapeutics firm
For Mankind, this is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis, and other muscle-wasting disorders.18-12-2023
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation of investment in Actimed Therapeutics Limited15-12-2023
Mankind Pharma stock drops nearly 5% on large block deals
Shares of Mankind Pharma fell 5% as 3.01 crore shares changed hands in a block deal on Tuesday. The buyers and sellers were not immediately known.12-12-2023
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of participation in Investor Meetings30-11-2023